Edesa Biotech Inc
EDSA
Get informed when a big investor buys or sells
+ FollowMarket Cap$64.2M
Close$
$1.90
72.3% downside
Current Fair Value
72.3% downsideOvervalued by 72.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $64.20 Million |
|---|---|
| Enterprise Value | $54.20 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.27 |
| Beta | 1.28 |
| Outstanding Shares | 8,253,715 |
Return
| Return on Equity | -84.33% |
|---|---|
| Return on Assets | -84.33% |
| Return on Invested Capital | -103.00% |
Valuation & Multiples
| P/E Ratio | -5.71 |
|---|---|
| PEG | -3.45 |
| Price to Sales | - |
| Price to Book Ratio | 6.86 |
| Enterprise Value to Revenue | 1064.38 |
| Enterprise Value to EBIT | -5.16 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.24
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 7, 2026
EPS Estimate
$-0.55
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 33.16%▼ 5.13% |
|---|---|
| Total Invested | $13.83M▲ 218.65% |
| Investors Holding | 27▲ 6.00% |
ESG Score
No data